Delegation of Authority, 19003 [07-1871]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 72 / Monday, April 16, 2007 / Notices
1600 Clifton Road, Mail Stop E–28,
Atlanta, GA 30303, telephone: 404/498–
0003, fax: 404/498–0059, E-mail:
smalcom@cdc.gov. The deadline for
notification of attendance is May 2,
2007.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: April 9, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–7188 Filed 4–13–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Michael O. Leavitt,
Secretary.
[FR Doc. 07–1871 Filed 4–13–07; 8:45 am]
Centers for Medicare and Medicaid
Services
BILLING CODE 4120–03–M
cprice-sewell on PROD1PC66 with NOTICES
Delegation of Authority
Notice is hereby given that I have
delegated to the Administrator of the
Centers for Medicare and Medicaid
Services, the following authority vested
in the Secretary of Health and Human
Services.
Subpoenas for the Health Insurance
Portability and Accountability Act of
1996 (HIPAA): Authority under Section
205(d) of the Social Security Act (42
U.S.C. 405(d)), with authority to
redelegate, to issue subpoenas requiring
the attendance and testimony of
witnesses and the production of any
evidence that relates to any matter
under investigation or compliance
review for failure to comply with the
Health Insurance Portability and
Accountability Act of 1996 (HIPAA)
standards and requirements related at
45 CFR parts 160, 162 and 164 (except
to the extent they pertain to the
standards for privacy of individually
identifiable health information).
Section 1176(a)(2) of the Social
Security Act, 42 U.S.C. 1320d–5(a)(2),
which provides authority for the
imposition of civil money penalties
(CMPs) for violations, makes section
1128A of the Social Security Act, 42
U.S.C. 1320a–7a, applicable to the
imposition of CMPs for violations of
HIPAA administrative simplification
standards. Section 1128A(j)(1), 42
U.S.C. 1320a–7a(j)(l), makes section
205(d) and (e) of the Social Security Act,
42 U.S.C. 405(d) and (e), applicable to
section 1128A as the subsections are
VerDate Aug<31>2005
15:24 Apr 13, 2007
Jkt 211001
with respect to Title II of the Social
Security Act. Section 205(d) and (e)
authorizes the issuance of subpoenas
requiring the attendance and testimony
of witnesses and the production of any
evidence that relates to any matter
under investigation by the Secretary and
the enforcement of such a subpoena in
court in event of refusal to comply.
This delegation shall be exercised
under the Department’s existing
delegation of authority on the issuance
of regulations and existing policy on the
issuance of regulations.
In addition, I hereby affirm and ratify
any actions taken by the Administrator
of the Centers for Medicare and
Medicaid Services, or his subordinates
which involved the exercise of the
authority delegated herein prior to the
effective date of this delegation.
This delegation is effective
immediately.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Vaccines and Related Biological
Products Advisory Committee; Notice
of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). At least one portion of the
meeting will be closed to the public.
Name of Committee: Vaccines and
Related Biological Products Advisory
Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on May 16, 2007, from 9 a.m. to
4:30 p.m. and on May 17, 2007, from 8
a.m. to 1 p.m.
Location: Hilton Hotel, Washington
DC North/Gaithersburg, 620 Perry
Pkwy., Gaithersburg, MD 20877.
Contact Person: Christine Walsh or
Denise Royster, Center for Biologics
Evaluation and Research (HFM–71),
Food and Drug Administration, 1401
Rockville Pike, Rockville, MD 20852,
301–827–0314, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
19003
Washington, DC area), code
3014512391. Please call the Information
Line for up-to-date information on this
meeting.
Agenda: On May 16, 2007, in the
morning session, the committee will
hear presentations and make
recommendations on the safety and
effectiveness of influenza virus vaccine
live (FluMist) in a pediatric population
less than 59 months of age,
manufactured by MedImmune Vaccines,
Inc. In the afternoon, the committee will
hear an overview of the function of the
Laboratory of Bacterial Polysaccharides
and the Laboratory of Enteric & Sexually
Transmitted Diseases, Division of
Bacterial Parasitic and Allergenic
Products, Office of Vaccines Research
and Review, CBER and in closed session
will discuss the report of the November
29, 2006, laboratory site visit. On May
17, 2007, the committee will hear
presentations and make
recommendations on the safety and
immunogenicity of a live vaccinia virus
smallpox vaccine (ACAM2000)
manufactured by Acambis, Inc.
FDA intends to make background
material available to the public no later
than 1 business day before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/ohrms/
dockets/ac/acmenu.htm, click on the
year 2007 and scroll down to the
appropriate advisory committee link.
Procedure: On May 16, 2007, from 9
a.m. to 3:50 p.m. and on May 17, 2007,
from 8 a.m. to 1 p.m., the meeting is
open to the public. Interested persons
may present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before May 2, 2007. Oral
presentations from the public will be
scheduled between approximately 11:45
a.m. to 12:15 p.m. and 3:20 p.m. to 3:50
p.m. on May 16, 2007, and between
approximately 11:15 a.m. to 11:45 a.m.
on May 17, 2007. Those desiring to
make formal oral presentations should
notify the contact person and submit a
brief statement of the general nature of
the evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before April 24, 2007. Time allotted
for each presentation may be limited. If
the number of registrants requesting to
E:\FR\FM\16APN1.SGM
16APN1
]]>Agencies
[Federal Register Volume 72, Number 72 (Monday, April 16, 2007)]
[Notices]
[Page 19003]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1871]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare and Medicaid Services
Delegation of Authority
Notice is hereby given that I have delegated to the Administrator
of the Centers for Medicare and Medicaid Services, the following
authority vested in the Secretary of Health and Human Services.
Subpoenas for the Health Insurance Portability and Accountability
Act of 1996 (HIPAA): Authority under Section 205(d) of the Social
Security Act (42 U.S.C. 405(d)), with authority to redelegate, to issue
subpoenas requiring the attendance and testimony of witnesses and the
production of any evidence that relates to any matter under
investigation or compliance review for failure to comply with the
Health Insurance Portability and Accountability Act of 1996 (HIPAA)
standards and requirements related at 45 CFR parts 160, 162 and 164
(except to the extent they pertain to the standards for privacy of
individually identifiable health information).
Section 1176(a)(2) of the Social Security Act, 42 U.S.C. 1320d-
5(a)(2), which provides authority for the imposition of civil money
penalties (CMPs) for violations, makes section 1128A of the Social
Security Act, 42 U.S.C. 1320a-7a, applicable to the imposition of CMPs
for violations of HIPAA administrative simplification standards.
Section 1128A(j)(1), 42 U.S.C. 1320a-7a(j)(l), makes section 205(d) and
(e) of the Social Security Act, 42 U.S.C. 405(d) and (e), applicable to
section 1128A as the subsections are with respect to Title II of the
Social Security Act. Section 205(d) and (e) authorizes the issuance of
subpoenas requiring the attendance and testimony of witnesses and the
production of any evidence that relates to any matter under
investigation by the Secretary and the enforcement of such a subpoena
in court in event of refusal to comply.
This delegation shall be exercised under the Department's existing
delegation of authority on the issuance of regulations and existing
policy on the issuance of regulations.
In addition, I hereby affirm and ratify any actions taken by the
Administrator of the Centers for Medicare and Medicaid Services, or his
subordinates which involved the exercise of the authority delegated
herein prior to the effective date of this delegation.
This delegation is effective immediately.
Michael O. Leavitt,
Secretary.
[FR Doc. 07-1871 Filed 4-13-07; 8:45 am]
BILLING CODE 4120-03-M
